APOEBC signature, which is derived from APOBEC3A and APOBEC3B cytosine deaminase activities, is one of the most common mutation signatures in different types of cancer, and it has been reported to be associated with tumorigenesis and drug resistance (28). Here, APOBEC3A is linked to cancer.